Nifty
Sensex
:
:
23547.75
74775.74
-359.40 (-1.50%)
-1092.06 (-1.44%)

Chemicals

Rating :
55/99

BSE: 543275 | NSE: ANURAS

1293.90
29-May-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1360.2
  •  1368
  •  1265
  •  1368.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1019264
  •  1335548960.6
  •  1415
  •  983.6

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14,655.69
  • 86.15
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 16,076.72
  • 0.12%
  • 4.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 59.07%
  • 4.25%
  • 23.92%
  • FII
  • DII
  • Others
  • 6.91%
  • 0.16%
  • 5.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.45
  • 12.12
  • -3.56

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.41
  • 15.40
  • -1.68

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.15
  • 5.84
  • -19.78

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 80.54
  • 85.31

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 4.04
  • 3.77

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 27.89
  • 26.17

Earnings Forecasts:

(Updated: 23-05-2026)
Description
2024
2025
2026
2027
Adj EPS
14.06
23
30.8
P/E Ratio
92.03
56.26
42.01
Revenue
2057.4
2396.13
2797.53
3647.6
EBITDA
516.6
624.27
742.33
844.1
Net Income
158.9
260.25
347.9
400.6
ROA
P/B Ratio
4.51
4.17
3.79
ROE
4.95
7.39
8.95
FCFF
266.09
398.99
229.5
FCFF Yield
1.56
2.34
1.34
Net Debt
938
543.65
55.85
119.9
BVPS
287.19
310.11
341.42

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
635.78
500.16
27.12%
512.45
390.14
31.35%
731.40
293.96
148.81%
485.83
254.20
91.12%
Expenses
498.49
355.70
40.14%
384.97
265.84
44.81%
595.61
213.55
178.91%
361.54
201.02
79.85%
EBITDA
137.29
144.45
-4.96%
127.48
124.30
2.56%
135.79
80.42
68.85%
124.29
53.18
133.72%
EBIDTM
21.59%
28.88%
24.88%
31.86%
18.57%
27.36%
25.58%
20.92%
Other Income
3.37
5.54
-39.17%
2.10
-3.55
-
7.79
1.93
303.63%
4.91
6.07
-19.11%
Interest
41.91
31.22
34.24%
35.16
31.96
10.01%
35.98
26.66
34.96%
35.66
22.38
59.34%
Depreciation
42.68
30.66
39.20%
34.47
29.29
17.69%
32.07
21.68
47.92%
30.68
20.65
48.57%
PBT
56.07
88.12
-36.37%
59.95
59.50
0.76%
75.53
34.02
122.02%
62.85
16.22
287.48%
Tax
0.07
25.19
-99.72%
-0.64
5.29
-
18.38
3.40
440.59%
14.39
4.01
258.85%
PAT
56.00
62.93
-11.01%
60.59
54.21
11.77%
57.15
30.62
86.64%
48.46
12.21
296.89%
PATM
8.81%
12.58%
11.82%
13.89%
7.81%
10.42%
9.97%
4.80%
EPS
3.75
4.05
-7.41%
4.31
2.56
68.36%
3.90
1.52
156.58%
3.10
0.36
761.11%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
2,365.46
1,436.97
1,475.07
1,601.90
1,073.77
810.89
528.88
501.50
342.77
288.31
287.80
Net Sales Growth
64.44%
-2.58%
-7.92%
49.18%
32.42%
53.32%
5.46%
46.31%
18.89%
0.18%
 
Cost Of Goods Sold
1,323.26
604.49
614.39
703.56
369.90
338.96
210.53
257.08
157.53
123.43
118.17
Gross Profit
1,042.20
832.49
860.68
898.35
703.87
471.93
318.35
244.41
185.24
164.88
169.62
GP Margin
44.06%
57.93%
58.35%
56.08%
65.55%
58.20%
60.19%
48.74%
54.04%
57.19%
58.94%
Total Expenditure
1,840.61
1,040.69
1,094.41
1,170.55
768.96
617.30
399.80
408.42
267.88
217.98
208.18
Power & Fuel Cost
-
1.44
1.17
0.77
0.00
0.00
0.00
0.00
25.64
25.29
20.10
% Of Sales
-
0.10%
0.08%
0.05%
0%
0%
0%
0%
7.48%
8.77%
6.98%
Employee Cost
-
73.61
75.14
68.90
48.50
32.44
21.09
18.59
15.92
12.94
12.37
% Of Sales
-
5.12%
5.09%
4.30%
4.52%
4.00%
3.99%
3.71%
4.64%
4.49%
4.30%
Manufacturing Exp.
-
245.76
295.92
294.85
288.27
202.75
130.04
104.40
8.18
6.71
8.94
% Of Sales
-
17.10%
20.06%
18.41%
26.85%
25.00%
24.59%
20.82%
2.39%
2.33%
3.11%
General & Admin Exp.
-
70.05
71.72
62.88
38.58
26.03
21.48
16.42
13.77
12.28
14.47
% Of Sales
-
4.87%
4.86%
3.93%
3.59%
3.21%
4.06%
3.27%
4.02%
4.26%
5.03%
Selling & Distn. Exp.
-
33.79
29.53
30.76
19.84
13.05
9.04
11.38
1.76
1.85
2.75
% Of Sales
-
2.35%
2.00%
1.92%
1.85%
1.61%
1.71%
2.27%
0.51%
0.64%
0.96%
Miscellaneous Exp.
-
11.55
6.53
8.82
3.87
4.07
7.62
0.54
45.08
35.48
2.75
% Of Sales
-
0.80%
0.44%
0.55%
0.36%
0.50%
1.44%
0.11%
13.15%
12.31%
10.90%
EBITDA
524.85
396.28
380.66
431.35
304.81
193.59
129.08
93.08
74.89
70.33
79.62
EBITDA Margin
22.19%
27.58%
25.81%
26.93%
28.39%
23.87%
24.41%
18.56%
21.85%
24.39%
27.67%
Other Income
18.17
16.06
30.25
8.57
7.34
26.61
16.56
19.52
6.41
10.91
7.88
Interest
148.71
112.22
89.43
62.66
30.83
68.54
45.26
24.35
14.56
21.12
21.26
Depreciation
139.90
102.28
79.70
71.08
60.12
51.65
28.71
22.53
17.57
15.38
12.56
PBT
254.40
197.85
241.77
306.19
221.20
100.00
71.67
65.72
49.16
44.74
53.68
Tax
32.20
37.88
74.33
90.81
69.68
29.71
18.46
15.51
9.27
9.95
11.03
Tax Rate
12.66%
19.15%
30.74%
29.66%
31.50%
29.71%
25.76%
23.60%
18.86%
22.24%
20.55%
PAT
222.20
93.35
128.60
180.85
152.18
70.30
53.21
50.21
39.89
34.79
42.65
PAT before Minority Interest
170.12
159.97
167.43
216.85
152.18
70.30
53.21
50.21
39.89
34.79
42.65
Minority Interest
-52.08
-66.62
-38.83
-36.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
9.39%
6.50%
8.72%
11.29%
14.17%
8.67%
10.06%
10.01%
11.64%
12.07%
14.82%
PAT Growth
38.90%
-27.41%
-28.89%
18.84%
116.47%
32.12%
5.97%
25.87%
14.66%
-18.43%
 
EPS
19.53
8.20
11.30
15.89
13.37
6.18
4.68
4.41
3.51
3.06
3.75

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,850.31
2,761.03
2,372.59
1,726.85
1,573.40
593.53
507.11
457.19
249.65
147.27
Share Capital
109.93
109.79
107.47
100.25
99.92
78.13
74.63
74.63
55.88
50.00
Total Reserves
2,646.59
2,556.78
2,254.15
1,622.45
1,472.85
515.41
432.48
382.56
193.77
97.27
Non-Current Liabilities
379.02
354.84
459.06
568.63
304.00
576.78
475.99
278.44
231.48
171.17
Secured Loans
171.18
191.26
280.24
360.52
58.01
265.21
220.28
268.42
222.51
164.02
Unsecured Loans
0.00
5.83
74.79
133.95
189.38
259.53
242.03
0.00
0.00
0.00
Long Term Provisions
1.89
1.49
1.10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
1,808.20
1,316.17
810.79
595.07
429.10
499.73
340.50
265.58
151.07
162.72
Trade Payables
576.38
415.19
322.57
227.78
199.63
130.15
73.80
62.09
52.64
33.64
Other Current Liabilities
190.69
195.16
231.41
140.45
153.85
119.20
107.67
75.49
35.68
36.02
Short Term Borrowings
1,029.03
698.20
235.71
208.08
42.77
237.11
154.41
122.98
57.40
89.41
Short Term Provisions
12.11
7.63
21.10
18.75
32.85
13.26
4.63
5.03
5.35
3.66
Total Liabilities
5,268.87
4,601.67
3,777.92
2,890.55
2,306.50
1,670.04
1,323.60
1,001.21
632.20
481.16
Net Block
2,184.53
1,501.40
1,417.24
1,202.23
1,115.07
977.34
680.89
382.21
312.57
259.12
Gross Block
2,778.74
1,994.18
1,830.37
1,427.24
1,287.12
1,098.03
782.00
460.99
373.79
304.99
Accumulated Depreciation
594.21
492.78
413.14
225.01
172.06
120.69
101.11
78.77
61.23
45.87
Non Current Assets
2,695.85
2,375.05
1,666.73
1,443.92
1,207.05
1,112.53
899.04
663.27
406.40
328.92
Capital Work in Progress
216.16
609.35
120.34
43.70
43.22
100.95
190.62
256.10
87.71
63.66
Non Current Investment
1.57
1.45
1.42
148.82
0.02
0.40
0.40
3.13
2.03
1.83
Long Term Loans & Adv.
291.25
262.13
126.70
44.08
48.72
32.36
22.54
18.22
4.09
4.32
Other Non Current Assets
2.34
0.72
1.03
5.08
0.01
1.49
4.59
3.61
0.00
0.00
Current Assets
2,573.04
2,226.62
2,111.19
1,446.63
1,099.46
557.51
424.56
337.94
225.81
152.24
Current Investments
6.99
65.17
65.62
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,451.50
1,055.32
931.47
863.19
492.22
297.04
195.37
172.52
103.13
75.48
Sundry Debtors
733.76
579.39
415.08
280.10
205.49
129.49
120.59
88.39
55.88
21.73
Cash & Bank
127.72
289.26
564.30
209.71
295.71
26.83
7.06
9.08
12.04
15.11
Other Current Assets
253.07
29.55
23.80
12.17
106.05
104.14
101.53
67.95
54.76
39.92
Short Term Loans & Adv.
222.90
207.93
110.92
81.46
96.56
102.42
98.43
66.08
50.97
38.69
Net Current Assets
764.83
910.45
1,300.40
851.56
670.36
57.78
84.06
72.36
74.74
-10.48
Total Assets
5,268.89
4,601.67
3,777.92
2,890.55
2,306.51
1,670.04
1,323.60
1,001.21
632.21
481.16

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
-30.13
59.03
292.07
-171.23
1.46
94.94
PBT
197.85
241.77
307.66
221.20
100.00
71.67
Adjustment
206.53
146.58
149.34
84.90
119.65
80.94
Changes in Working Capital
-391.73
-282.07
-95.67
-441.57
-200.63
-48.44
Cash after chg. in Working capital
12.65
106.27
361.34
-135.47
19.02
104.17
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-42.77
-47.24
-69.27
-35.76
-17.56
-9.23
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-329.91
-392.11
-522.66
-412.04
-193.08
-178.20
Net Fixed Assets
-289.65
-571.75
-177.70
-140.45
-130.78
Net Investments
-0.05
-0.99
-10.28
-148.14
0.40
Others
-40.21
180.63
-334.68
-123.45
-62.70
Cash from Financing Activity
223.27
395.07
370.64
384.36
415.77
101.87
Net Cash Inflow / Outflow
-136.76
61.99
140.06
-198.91
224.15
18.62
Opening Cash & Equivalents
249.80
187.81
47.75
241.17
17.02
-1.60
Closing Cash & Equivalent
113.05
249.80
187.81
42.26
241.17
17.02

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 16
Book Value (Rs.)
250.75
242.89
219.76
171.85
157.40
113.08
29.45
ROA
3.24%
4.00%
6.50%
5.86%
3.54%
3.55%
8.86%
ROE
5.90%
6.66%
10.62%
9.24%
6.58%
10.15%
28.96%
ROCE
7.80%
9.54%
13.03%
11.27%
10.00%
9.03%
17.59%
Fixed Asset Turnover
0.60
0.77
0.98
0.79
0.68
0.56
1.00
Receivable days
166.77
123.04
79.20
82.53
75.39
86.30
25.98
Inventory Days
318.37
245.81
204.46
230.37
177.63
169.92
90.26
Payable days
299.36
219.15
142.76
210.87
177.56
83.14
82.49
Cash Conversion Cycle
185.79
149.70
140.90
102.03
75.47
173.07
33.75
Total Debt/Equity
0.48
0.38
0.33
0.46
0.25
1.38
1.89
Interest Cover
2.76
3.70
5.91
8.20
2.46
2.58
3.53

News Update:


  • Anupam Rasayan India raises Rs 160 crore through NCDs
    27th May 2026, 15:10 PM

    The NCDs are set to mature on June 26, 2027

    Read More
  • Anupam Rasayan inks definitive pact to acquire 43.3% stake in Bliss GVS Pharma
    25th May 2026, 11:52 AM

    This will strategically strengthen the company’s presence across the pharmaceutical value chain, spanning KSMs to finished dosage formulations

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.